↓ Skip to main content

Implication of plasma intermedin levels in patients who underwent first-time diagnostic coronary angiography: a single centre, cross-sectional study

Overview of attention for article published in BMC Cardiovascular Disorders, December 2014
Altmetric Badge

Readers on

mendeley
6 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Implication of plasma intermedin levels in patients who underwent first-time diagnostic coronary angiography: a single centre, cross-sectional study
Published in
BMC Cardiovascular Disorders, December 2014
DOI 10.1186/1471-2261-14-182
Pubmed ID
Authors

Aylin Hatice Yamac, Ahmet Bacaksiz, Ziya Ismailoglu, Sitki Kucukbuzcu, Emrah Sevgili, Emin Asoglu, Muharrem Nasifov, Parviz Jafarov, Ercan Erdogan, Omer Goktekin

Abstract

Intermedin (IMD) is involved in the prevention of atherosclerotic plaque progression, possessing cardioprotective effects from hypertrophy, fibrosis and ischemia-reperfusion injury. Elevated plasma IMD levels have been demonstrated in patients with acute coronary syndromes. No human study has examined the role of IMD in stable patients who underwent diagnostic coronary angiography with suspicion of coronary artery disease (CAD). Thus we investigated the role of IMD as a biomarker to discriminate patients with CAD and predict those with severe disease who require early and intensive therapeutic intervention before presenting with acute coronary syndrome.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 33%
Librarian 1 17%
Researcher 1 17%
Other 1 17%
Unknown 1 17%
Readers by discipline Count As %
Medicine and Dentistry 5 83%
Unknown 1 17%